Gregory Cheng

9.9k total citations · 4 hit papers
87 papers, 6.1k citations indexed

About

Gregory Cheng is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Gregory Cheng has authored 87 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 15 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Gregory Cheng's work include Platelet Disorders and Treatments (30 papers), Blood groups and transfusion (21 papers) and Autoimmune Bullous Skin Diseases (12 papers). Gregory Cheng is often cited by papers focused on Platelet Disorders and Treatments (30 papers), Blood groups and transfusion (21 papers) and Autoimmune Bullous Skin Diseases (12 papers). Gregory Cheng collaborates with scholars based in Hong Kong, China and United States. Gregory Cheng's co-authors include Raymond Wong, Huang Changquan, Huacong Deng, James B. Bussel, M. Arning, Mansoor N. Saleh, Bhabita Mayer, Nicole L. Stone, Joyce H. S. You and Paul K.S. Chan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Gregory Cheng

84 papers receiving 5.9k citations

Hit Papers

Diabetes as a risk factor for dementia and mild cogniti... 2004 2026 2011 2018 2012 2004 2007 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta‐analysis of longitudinal studies
    2012 749 citations Gregory Cheng et al. profile →
  2. Use of convalescent plasma therapy in SARS patients in Hong Kong
    2004 674 citations Yi‐Chang Cheng, Raymond Wong et al. European Journal of Clinical Microbiology & Infectious Diseases profile →
  3. Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
    2007 565 citations James B. Bussel, Gregory Cheng et al. New England Journal of Medicine profile →
  4. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score
    2020 391 citations Dong Ji, Dawei Zhang et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Cheng Hong Kong 32 2.4k 1.3k 643 542 534 87 6.1k
Stuart D. Katz United States 48 1.3k 0.5× 686 0.5× 5.5k 8.6× 446 0.8× 1.0k 1.9× 230 9.4k
Tadao Akizawa Japan 53 2.9k 1.2× 153 0.1× 1.1k 1.7× 1.0k 1.9× 751 1.4× 442 13.6k
Der‐Cherng Tarng Taiwan 37 565 0.2× 157 0.1× 636 1.0× 337 0.6× 464 0.9× 218 4.7k
Akira Hishida Japan 48 728 0.3× 322 0.2× 2.7k 4.3× 428 0.8× 1.1k 2.1× 298 13.6k
Adrian Covic Romania 55 763 0.3× 161 0.1× 1.8k 2.8× 324 0.6× 819 1.5× 314 9.4k
Peter Bárány Sweden 55 1.6k 0.7× 117 0.1× 1.2k 1.9× 434 0.8× 2.3k 4.3× 233 11.1k
Gurkirpal Singh United States 43 1.1k 0.5× 72 0.1× 853 1.3× 290 0.5× 654 1.2× 122 8.0k
Lesley A. Inker United States 54 595 0.2× 302 0.2× 3.0k 4.7× 226 0.4× 951 1.8× 221 14.1k
Kunihiro Yamagata Japan 43 542 0.2× 267 0.2× 2.6k 4.0× 378 0.7× 1.3k 2.4× 316 12.5k
Uzi Gafter Israel 41 786 0.3× 149 0.1× 710 1.1× 400 0.7× 644 1.2× 174 6.8k

Countries citing papers authored by Gregory Cheng

Since Specialization
Citations

This map shows the geographic impact of Gregory Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cheng more than expected).

Fields of papers citing papers by Gregory Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cheng. The network helps show where Gregory Cheng may publish in the future.

Co-authorship network of co-authors of Gregory Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Cheng. A scholar is included among the top collaborators of Gregory Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Cheng. Gregory Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Dong, Guofeng Chen, Xiao-Xia Niu, et al.. (2021). Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. SHILAP Revista de lepidopterología. 10. 100090–100090. 23 indexed citations
2.
3.
Zhang, Mingjie, et al.. (2020). Safety and efficacy of eltrombopag plus pulsed dexamethasone as first‐line therapy for immune thrombocytopenia. British Journal of Haematology. 189(2). 369–378. 32 indexed citations
4.
Ji, Dong, Dawei Zhang, Jing Xu, et al.. (2020). Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score. Clinical Infectious Diseases. 71(6). 1393–1399. 391 indexed citations breakdown →
5.
Zhang, Mingjie, et al.. (2018). Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP). Blood. 132(Supplement 1). 733–733. 3 indexed citations
6.
Tsui, Nancy B. Y., Gregory Cheng, Christopher Wai Kei Lam, et al.. (2018). Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning. Scientific Reports. 8(1). 1853–1853. 5 indexed citations
7.
Powell, Jerry S., Neil C. Josephson, Doris Quon, et al.. (2012). Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. Blood. 119(13). 3031–3037. 171 indexed citations
8.
9.
Bussel, James B., Gregory Cheng, Mansoor N. Saleh, et al.. (2007). Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 357(22). 2237–2247. 565 indexed citations breakdown →
10.
You, Joyce H. S., et al.. (2005). Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate‐intensity anticoagulation?. British Journal of Clinical Pharmacology. 59(5). 582–587. 107 indexed citations
11.
Veenstra, David L., Joyce H. S. You, Mark J. Rieder, et al.. (2005). Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Pharmacogenetics and Genomics. 15(10). 687–691. 133 indexed citations
12.
Soo, Y.O.Y., Yi‐Chang Cheng, Raymond Wong, et al.. (2004). Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clinical Microbiology and Infection. 10(7). 676–678. 284 indexed citations
13.
Cheng, Yi‐Chang, Raymond Wong, Y.O.Y. Soo, et al.. (2004). Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases. 24(1). 44–46. 674 indexed citations breakdown →
14.
Chui, Chung, Fung Lau, Raymond Wong, et al.. (2001). Vitamin B12 deficiency—need for a new guideline. Nutrition. 17(11-12). 917–920. 31 indexed citations
15.
Cheng, Gregory, et al.. (2001). To err is human nature. Can transfusion errors due to human factors ever be eliminated?. Clinica Chimica Acta. 313(1-2). 59–67. 12 indexed citations
16.
Tse, Hung‐Fat, Chu‐Pak Lau, & Gregory Cheng. (1997). Relation Between Mitral Regurgitation and Platelet Activation. Journal of the American College of Cardiology. 30(7). 1813–1818. 48 indexed citations
17.
18.
Cheng, Gregory, et al.. (1996). Provision of an out-of-hours blood banking service at a satellite hospital without blood bank staff. Clinical & Laboratory Haematology. 18(3). 201–205. 2 indexed citations
19.
Cheng, Gregory, et al.. (1995). Haemolytic transfusion reactions due to Mi-antibodies; need to include MiltenbergerIII positive cells in pre-transfusion antibody screening in Hong Kong.. PubMed. 17(2). 183–4. 14 indexed citations
20.
Cheng, Gregory, et al.. (1992). A PATIENT WITH MARKED LEUCOCYTOSIS, t(8;21), ABSENT PHILADELPHIA CHROMOSOME, BUT REARRANGED BCR GENE. British Journal of Haematology. 82(1). 171–172. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stuart D. Katz Breakdown of academic impact, for papers by Tadao Akizawa Breakdown of academic impact, for papers by Der‐Cherng Tarng Breakdown of academic impact, for papers by Akira Hishida Breakdown of academic impact, for papers by Adrian Covic Breakdown of academic impact, for papers by Peter Bárány Breakdown of academic impact, for papers by Gurkirpal Singh Breakdown of academic impact, for papers by Lesley A. Inker Breakdown of academic impact, for papers by Kunihiro Yamagata Breakdown of academic impact, for papers by Uzi Gafter
Rankless by CCL
2026